News for Ensysce Biosciences, Inc. (ENSC)

SAN DIEGO, CA / ACCESS Newswire / April 24, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing i

Ensysce Biosciences (ENSC) secures $2.2 million in gross proceeds through warrant exercise. New warrants issued allow purchase of 1,260,752 shares at an

Japan-based Linkage Global Inc (LGCB) is up over 24 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of ServiceNow, Inc. NOW rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Serv...

Ensysce Biosciences, Inc. (ENSC) raises $2.2 million through warrant exercises, bolstering its pain management development initiatives. Analysts predict

Ensysce Biosciences shares skyrocket nearly 100% after securing a key patent for its innovative methadone prodrug. Analysts project significant upside p

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 23, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company deve

Key Highlights: Ensysce Biosciences has raised approximately $2.2 million through strategic warrant agreements. New warrants are set to be issued, potent

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 500 points on Wednesday. The Dow traded up 1.29% to 39,693.36 whil...

Ensysce Biosciences Inc (ENSC) has concluded the first part of its key clinical trial for PF614-MPAR, showcasing enhanced safety in opioid use. Wall Str

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

In a noteworthy trend, NovaBay Pharmaceuticals (NBY) and several other biotech companies are witnessing significant increases in search activity today, as highl

Ensysce Biosciences (ENSC) has recently filed to offer 652,439 shares of its common stock. This move, while still preliminary, could signal important shifts in

New Hampshire-based iCAD, Inc. (ICAD) is up over 67 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~~ Panel Discussion Posted to Ensysce's Corporate Website ~ SAN DIEGO, CA / ACCES

Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPARGroundbreaking Trial on PF614-MPAR Generates Positive Interim Res

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Today's Marketplace (TMP) is proud to announce a featured interview with Ensysce

Significant Transaction in Ensysce Biosciences Inc On December 31, 2024, Anson Funds Management LP (Trades, Portfolio) executed a noteworthy transaction by acqu